NO943791L - 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin - Google Patents

1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin

Info

Publication number
NO943791L
NO943791L NO943791A NO943791A NO943791L NO 943791 L NO943791 L NO 943791L NO 943791 A NO943791 A NO 943791A NO 943791 A NO943791 A NO 943791A NO 943791 L NO943791 L NO 943791L
Authority
NO
Norway
Prior art keywords
dihydro
oxo
metylsulfonylaminometylpyridin
atoms
represents alkyl
Prior art date
Application number
NO943791A
Other languages
English (en)
Other versions
NO943791D0 (no
Inventor
Mathias Osswald
Werner Mederski
Dieter Dorsch
Pierre Schelling
Norbert Beier
Klaus-Otto Minck
Ingeborg Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO943791D0 publication Critical patent/NO943791D0/no
Publication of NO943791L publication Critical patent/NO943791L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Nye 1,2-dihydro-2-okso-3-metyl-sulfonylaminometylpyridiner med formel. I. hvor Rbetyr alkyl med 1-5 C-atomer,. Rbetyr CN eller lH-5-tetrazolyl, og Rbetyr alkyl med 1-5 C-atomer eller syklopropylmetyl, samt salter derav har angiotensin II-antagonistiske egen-skaper og kan anvendes til behandling av hypertensjon, aldosteronisme og hjerteinsuffisiens.
NO943791A 1993-10-08 1994-10-07 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin NO943791L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4334308A DE4334308A1 (de) 1993-10-08 1993-10-08 1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridine

Publications (2)

Publication Number Publication Date
NO943791D0 NO943791D0 (no) 1994-10-07
NO943791L true NO943791L (no) 1995-04-10

Family

ID=6499685

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943791A NO943791L (no) 1993-10-08 1994-10-07 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin

Country Status (14)

Country Link
EP (1) EP0647627A1 (no)
JP (1) JPH07188171A (no)
KR (1) KR950011410A (no)
CN (1) CN1106387A (no)
AU (1) AU7438694A (no)
CA (1) CA2133804A1 (no)
CZ (1) CZ240194A3 (no)
DE (1) DE4334308A1 (no)
HU (1) HUT70555A (no)
NO (1) NO943791L (no)
PL (1) PL305354A1 (no)
RU (1) RU94036750A (no)
SK (1) SK121494A3 (no)
ZA (1) ZA947884B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4336051A1 (de) * 1993-10-22 1995-04-27 Merck Patent Gmbh 1,2-Dihydro-2-oxo-pyridine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4129340A1 (de) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-oxopyridine

Also Published As

Publication number Publication date
HUT70555A (en) 1995-10-30
CZ240194A3 (en) 1995-04-12
RU94036750A (ru) 1996-09-10
PL305354A1 (en) 1995-04-18
EP0647627A1 (de) 1995-04-12
CN1106387A (zh) 1995-08-09
HU9402902D0 (en) 1995-02-28
JPH07188171A (ja) 1995-07-25
DE4334308A1 (de) 1995-04-13
NO943791D0 (no) 1994-10-07
ZA947884B (en) 1995-05-22
KR950011410A (ko) 1995-05-15
SK121494A3 (en) 1995-05-10
CA2133804A1 (en) 1995-04-09
AU7438694A (en) 1995-04-27

Similar Documents

Publication Publication Date Title
BG104597A (en) Inhibition of raf kinase using substituted heterocyclic ureas
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
NO944689L (no) Imidazopyrider
NZ325449A (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
NO922851L (no) Trifluormetylbenzylfosfonater som er nyttig for behandling av osteporose
DE59204339D1 (de) Derivate der 4-hydroxy-buttersäure.
RU94040174A (ru) Гетероциклические соединения, способ их получения, фармкомпозиция и способ лечения
ATE198708T1 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
NO920298L (no) 2,3,6-substituerte kinazolinoner
DK130387D0 (da) Transglutaminase inhibitorer
NO924121D0 (no) Substituerte pyrimidiner
DE68929540D1 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
CA2063926A1 (en) Imidazopyridine
DE60140695D1 (de) Anilinopyrimidinderivate als ikk?inhibitoren, und hiermit in zusammenhang stehende zusammensetzungen und verfahren
NO942095L (no) Imidazopyridiner
ES8700666A1 (es) Procedimiento para la preparacion de derivados de 2-(piridi-lalquilenosulfinil)benzimidazoles n-substituidos como agen- tes antisecretorios gastricos
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
BG96645A (bg) Етилендиаминови моноамиди
CA2256687A1 (en) Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
MY106474A (en) Guanidine derivatives.
EP0235064A3 (en) Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing uvb and/or uva
NO943791L (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
NZ331789A (en) Method of treating heart failure with non-peptide endothelin antagonists